BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 6340167)

  • 1. [Protein chemistry of the complement system].
    Nagasawa S
    Tanpakushitsu Kakusan Koso; 1983 Jan; 28(1):18-44. PubMed ID: 6340167
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proteases in complement system (author's transl)].
    Nagasawa S
    Tanpakushitsu Kakusan Koso; 1980; 25(6):531-46. PubMed ID: 7010425
    [No Abstract]   [Full Text] [Related]  

  • 3. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.
    Sobel AT; Cooper NR; Schreiber RD
    J Immunol; 1979 Jan; 122(1):34-8. PubMed ID: 762421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
    Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
    Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in the knowledge of complement. I. Structure, activation and control of the complement system].
    Lesavre P; Leibowitch J
    Nouv Presse Med; 1979 Jun; 8(29):2385-7. PubMed ID: 493022
    [No Abstract]   [Full Text] [Related]  

  • 7. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement factors and acute phase reactants in the Guillain-Barré syndrome.
    Tönnessen TI; Nyland H; Aarli JA
    Eur Neurol; 1982; 21(2):124-8. PubMed ID: 6920298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Structure and function of alternative pathway components of complement].
    Tomita M; Sugita Y
    Tanpakushitsu Kakusan Koso; 1986 Jul; 31(9 Suppl):847-64. PubMed ID: 3641329
    [No Abstract]   [Full Text] [Related]  

  • 10. [Complement: mechanisms of activation, functions, analysis].
    Dessaint JP; Wattre P; Santoro F; Capron A
    Lille Med; 1979; 24(7):551-8. PubMed ID: 397392
    [No Abstract]   [Full Text] [Related]  

  • 11. [Progress on complement protein chemistry and the molecular mechanism of activation. Standard complement pathway].
    Nagasawa S
    Nihon Rinsho; 1988 Sep; 46(9):1889-93. PubMed ID: 3241382
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure and molecular genetics of complement proteins. An update.
    Volanakis JE
    Year Immunol; 1986; 2():164-76. PubMed ID: 3554821
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activation and regulation of the proteinases in the complement system].
    Nagasawa S
    Tanpakushitsu Kakusan Koso; 1986 Jul; 31(9 Suppl):831-46. PubMed ID: 3538196
    [No Abstract]   [Full Text] [Related]  

  • 14. Current concepts in immunology: the alternative pathway of complement--a system for host resistance to microbial infection.
    Fearon DT; Austen KF
    N Engl J Med; 1980 Jul; 303(5):259-63. PubMed ID: 6900901
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanism of complement activity].
    Chenchikova EP
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jul; (7):21-31. PubMed ID: 308752
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5.
    Strunk RC; Giclas PC
    J Immunol; 1980 Feb; 124(2):520-6. PubMed ID: 7356706
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitation of (C1INH)2 C1r-C1s complexes in glomerulonephritis as an indicator of C1 activation.
    Waldo FB; West CD
    Clin Immunol Immunopathol; 1987 Feb; 42(2):239-49. PubMed ID: 3026704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complement factors in the medical analysis laboratory].
    Laurell AB
    Ric Clin Lab; 1978; 8 Suppl 2():61-74. PubMed ID: 106451
    [No Abstract]   [Full Text] [Related]  

  • 19. The biological role of the complement system and the clinical importance of complement measurements.
    Füst G
    Haematologia (Budap); 1978-1979; 12(1-4):85-106. PubMed ID: 395046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in the immunochemical studies of complement--including the establishment of nomenclature of complement proteins].
    Inai S
    Nihon Rinsho; 1979 May; 37(5):923-9. PubMed ID: 381722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.